234 related articles for article (PubMed ID: 21232114)
1. Brimonidine prevents axonal and somatic degeneration of retinal ganglion cell neurons.
Lambert WS; Ruiz L; Crish SD; Wheeler LA; Calkins DJ
Mol Neurodegener; 2011 Jan; 6(1):4. PubMed ID: 21232114
[TBL] [Abstract][Full Text] [Related]
2. Neuroprotection of retinal ganglion cells by brimonidine in rats with laser-induced chronic ocular hypertension.
WoldeMussie E; Ruiz G; Wijono M; Wheeler LA
Invest Ophthalmol Vis Sci; 2001 Nov; 42(12):2849-55. PubMed ID: 11687528
[TBL] [Abstract][Full Text] [Related]
3. Neuroprotective effect of alpha(2) agonist (brimonidine) on adult rat retinal ganglion cells after increased intraocular pressure.
Ahmed FA; Hegazy K; Chaudhary P; Sharma SC
Brain Res; 2001 Sep; 913(2):133-9. PubMed ID: 11549376
[TBL] [Abstract][Full Text] [Related]
4. Transient ischemia of the retina results in massive degeneration of the retinotectal projection: long-term neuroprotection with brimonidine.
Avilés-Trigueros M; Mayor-Torroglosa S; García-Avilés A; Lafuente MP; Rodríguez ME; Miralles de Imperial J; Villegas-Pérez MP; Vidal-Sanz M
Exp Neurol; 2003 Dec; 184(2):767-77. PubMed ID: 14769369
[TBL] [Abstract][Full Text] [Related]
5. Axon hyperexcitability in the contralateral projection following unilateral optic nerve crush in mice.
McGrady NR; Holden JM; Ribeiro M; Boal AM; Risner ML; Calkins DJ
Brain Commun; 2022; 4(5):fcac251. PubMed ID: 36267329
[TBL] [Abstract][Full Text] [Related]
6. Absence of transient receptor potential vanilloid-1 accelerates stress-induced axonopathy in the optic projection.
Ward NJ; Ho KW; Lambert WS; Weitlauf C; Calkins DJ
J Neurosci; 2014 Feb; 34(9):3161-70. PubMed ID: 24573275
[TBL] [Abstract][Full Text] [Related]
7. Axonal protection by brimonidine with modulation of p62 expression in TNF-induced optic nerve degeneration.
Kitaoka Y; Kojima K; Munemasa Y; Sase K; Takagi H
Graefes Arch Clin Exp Ophthalmol; 2015 Aug; 253(8):1291-6. PubMed ID: 25863674
[TBL] [Abstract][Full Text] [Related]
8. Prevention of retinal ganglion cell swelling by systemic brimonidine in a rat experimental glaucoma model.
Pinar-Sueiro S; Urcola H; Rivas MA; Vecino E
Clin Exp Ophthalmol; 2011 Nov; 39(8):799-807. PubMed ID: 21631673
[TBL] [Abstract][Full Text] [Related]
9. Neuroprotective effects of brimonidine treatment in a rodent model of ischemic optic neuropathy.
Danylkova NO; Alcala SR; Pomeranz HD; McLoon LK
Exp Eye Res; 2007 Feb; 84(2):293-301. PubMed ID: 17113077
[TBL] [Abstract][Full Text] [Related]
10. Alpha-2 adrenergic receptor agonists are neuroprotective in experimental models of glaucoma.
Wheeler LA; Woldemussie E
Eur J Ophthalmol; 2001; 11 Suppl 2():S30-5. PubMed ID: 11592528
[TBL] [Abstract][Full Text] [Related]
11. Assessment of retinal ganglion cell damage in glaucomatous optic neuropathy: Axon transport, injury and soma loss.
Nuschke AC; Farrell SR; Levesque JM; Chauhan BC
Exp Eye Res; 2015 Dec; 141():111-24. PubMed ID: 26070986
[TBL] [Abstract][Full Text] [Related]
12. Ocular hypertension impairs optic nerve axonal transport leading to progressive retinal ganglion cell degeneration.
Salinas-Navarro M; Alarcón-Martínez L; Valiente-Soriano FJ; Jiménez-López M; Mayor-Torroglosa S; Avilés-Trigueros M; Villegas-Pérez MP; Vidal-Sanz M
Exp Eye Res; 2010 Jan; 90(1):168-83. PubMed ID: 19835874
[TBL] [Abstract][Full Text] [Related]
13. Effect of brimonidine on retinal ganglion cell survival in an optic nerve crush model.
Ma K; Xu L; Zhang H; Zhang S; Pu M; Jonas JB
Am J Ophthalmol; 2009 Feb; 147(2):326-31. PubMed ID: 18835468
[TBL] [Abstract][Full Text] [Related]
14. Reduced retina microglial activation and improved optic nerve integrity with minocycline treatment in the DBA/2J mouse model of glaucoma.
Bosco A; Inman DM; Steele MR; Wu G; Soto I; Marsh-Armstrong N; Hubbard WC; Calkins DJ; Horner PJ; Vetter ML
Invest Ophthalmol Vis Sci; 2008 Apr; 49(4):1437-46. PubMed ID: 18385061
[TBL] [Abstract][Full Text] [Related]
15. Protection of retinal ganglion cells and the optic nerve during short-term hyperglycemia in experimental glaucoma.
Ebneter A; Chidlow G; Wood JP; Casson RJ
Arch Ophthalmol; 2011 Oct; 129(10):1337-44. PubMed ID: 21987677
[TBL] [Abstract][Full Text] [Related]
16. Effects of a non-selective beta-blocker on adult rat anterograde axonal transport and retinal ganglion layer after increased intraocular pressure.
Díaz F; Villena A; Moreno M; Vidal L; Parrado C; García-Campos J; de Vargas IP
Histol Histopathol; 2005 Oct; 20(4):1077-84. PubMed ID: 16136490
[TBL] [Abstract][Full Text] [Related]
17. Intravitreal delivery of human NgR-Fc decoy protein regenerates axons after optic nerve crush and protects ganglion cells in glaucoma models.
Wang X; Lin J; Arzeno A; Choi JY; Boccio J; Frieden E; Bhargava A; Maynard G; Tsai JC; Strittmatter SM
Invest Ophthalmol Vis Sci; 2015 Feb; 56(2):1357-66. PubMed ID: 25655801
[TBL] [Abstract][Full Text] [Related]
18. Retinal ganglion cell neuroprotection in a rat model of glaucoma following brimonidine, latanoprost or combined treatments.
Hernández M; Urcola JH; Vecino E
Exp Eye Res; 2008 May; 86(5):798-806. PubMed ID: 18394603
[TBL] [Abstract][Full Text] [Related]
19. The growth factor response in ischemic rat retina and superior colliculus after brimonidine pre-treatment.
Lönngren U; Näpänkangas U; Lafuente M; Mayor S; Lindqvist N; Vidal-Sanz M; Hallböök F
Brain Res Bull; 2006 Dec; 71(1-3):208-18. PubMed ID: 17113948
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-6 Deficiency Attenuates Retinal Ganglion Cell Axonopathy and Glaucoma-Related Vision Loss.
Echevarria FD; Formichella CR; Sappington RM
Front Neurosci; 2017; 11():318. PubMed ID: 28620279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]